Document is current
Any future updates will be listed below
-
Authors
Amstutz, C. http://orcid.org/0000-0003-2755-8138
Ilic, M.
Fontaine, N.
Siegenthaler, L.
Illi, J.
Haeberlin, A. http://orcid.org/0000-0002-9283-0110
Zurbuchen, A. http://orcid.org/0000-0003-0920-378X
Burger, J.
-
Funding
Funding for this research was provided by:
Innosuisse - Schweizerische Agentur für Innovationsförderung (32091.1 IP-LS)
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 22 July 2024
First Online: 30 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: During this investigation, C. Amstutz and J. Burger collaborated closely with SIS Medical AG and Swiss Medical Device AG. Dr. Haeberlin has received travel fees/educational grants from Medtronic, Biotronik, Abbott, and Philips/Spectranetics without impacting his personal remuneration. He serves as a proctor for Medtronic. He is the Co-founder and CEO of Act-Inno AG. L. Siegenthaler is currently employed at Abbott.
